Chemoinformaics analysis of 25-O-acetylcimigenol xyloside
| Molecular Weight | 662.861 | nRot | 4 |
| Heavy Atom Molecular Weight | 604.397 | nRig | 37 |
| Exact Molecular Weight | 662.403 | nRing | 8 |
| Solubility: LogS | -3.872 | nHRing | 3 |
| Solubility: LogP | 4.65 | No. of Aliphatic Rings | 8 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 105 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 47 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 58 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 37 | No. of Saturated Rings | 8 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 0 |
| nHA | 10 | APOL | 108.484 |
| nHD | 4 | BPOL | 67.734 |
| QED | 0.26 |
| Synth | 7.386 |
| Natural Product Likeliness | 3.198 |
| NR-PPAR-gamma | 0.925 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.945 |
| Pgp-sub | 0.095 |
| HIA | 0.008 |
| CACO-2 | -5.365 |
| MDCK | 0.0000236 |
| BBB | 0.005 |
| PPB | 0.863095 |
| VDSS | 0.787 |
| FU | 0.0840837 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.639 |
| CYP2c19-inh | 0.004 |
| CYP2c19-sub | 0.617 |
| CYP2c9-inh | 0.03 |
| CYP2c9-sub | 0.009 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.158 |
| CYP3a4-inh | 0.332 |
| CYP3a4-sub | 0.21 |
| CL | 1.342 |
| T12 | 0.539 |
| hERG | 0.837 |
| Ames | 0.017 |
| ROA | 0.659 |
| SkinSen | 0.57 |
| Carcinogencity | 0.015 |
| EI | 0.013 |
| Respiratory | 0.982 |
| NR-Aromatase | 0.828 |
| Antiviral | Yes |
| Prediction | 0.871834 |